Business and Finance Business and Finance
Thu, October 8, 2009
Wed, October 7, 2009

Clenergen Corporation: Clenergen Corporation (CRGE OB) Signs Memorandum of Agreement With Leading Scientific Research and Devel


Published on 2009-10-07 19:38:14 - Market Wire
  Print publication without navigation


NEW YORK, NEW YORK--(Marketwire - Oct. 7, 2009) - Clenergen Corporation (OTCBB:CRGE) today announced that it has signed a Memorandum of Agreement (MOA) with Enhanced Biofuels & Technologies India (P) Ltd to form a new research and development company. The new company will be called Biomass2Biopower Private Limited (B2B)and will be focused on bio energy research and development, with a view of evaluating a variety of species of tree (Casuarinas , Eucalyptus, Luciana's, Vanashree, Acacia, Prosopis Juliflora and grasses as future potential supplies of cultivated non edible biomass feedstock's. EBTI's business is the delivery of end to end solutions for biopower, designed to support all segments of the supply chain associated with the production of renewable energy, bio pesticides, bio fertilizers and other high value commodities derived from the processing of various biomass resources.

B2B has evolved a highly integrated complimentary operational profile that embraces a team of scientific and technical skills drawn from some of the world's foremost research, academic, Industrial, policy and financial sectors.

The Scientific Advisory Council headed up by Dr. W. Selvamurthy (Distinguished Scientist and Chief Controller for the Defense Research and Development Organization, Ministry of Defence, Govt of India) consisting of the following eminent scientists:



Prof C. Surendran Distinguished Scientist and expert in Genetics
and Plant Breeding - Forestry Species
Prof R. Jayarajan Distinguished Scientist and Expert Microbiology
and Plant Pathology
Prof A.Gopalan Distinguished Scientist and Expert in Genetics
Plant Breeding - Grass Species
Prof S.R. Sreerengasamy Distinguished Scientist and Expert Genetic
Engineering and Molecular Biology
Prof V. Murugappan Distinguished Scientist Soil Crop Management
Dr Ponnaiah Rethinam Agronomy and crop production - Plantation crops
Prof T.N.Balasubramanian Distinguished Scientist, Irrigation and
Microclimate
Prof M.K.Ayyasamy Distinguished Scientist Statistics
Dr KV Ahammed Bavappa Distinguished Scientist, FAO Consultant and
Expert in Plantation crop management
Dr H.Hameed Khan Expert Plantation crops
Prof A. Regupathy Distinguished Scientist Expert Entomology
Prof D.Dharmalingam Distinguished Scientist, Expert Seed technology
Dr G.Sakkarai Expert Agricultural Extension
Dr AK Gupta Distinguished Scientist and Expert Biofuel and
Bioenergy technologies
Prof Ilangovan Kuppuswamy Distinguished Nanotechnology Scientist-Mexico
University
Prof Nandhi.S.Bolan Distinguished Phytoremediation Scientist,
Massey University, New Zealand
Prof L.Kothandapan Distinguished Process Engineering Professor,
Tamilnadu University
Prof. Udayakumar Distinguished Bioremediation Scientist,
Gandhigram University
Professor K.Balraman Distinguished Plant Pathology Scientist,
Indian Institute of Horticulture Research
Prof R.K. Sivanappan Distinguished Irrigation and Water Management
Scientist, Tamilnadu University)



Commenting on the new Joint Venture Company, Mark Quinn, CEO of Clenergen said "The wealth of scientific knowledge of the Scientific Advisory Council provides Clenergen the best possible plant science resources for its feedstock cultivation program, along with a variety of alternative species of tree and grass which can be adopted for specific climatic conditions. B2B will generate revenue from the sale of its bio pesticides and bio fertilizers as well as out sourcing planting materials to third parties for the purpose of cultivating biomass feedstock on behalf of Clenergen Corporation".

Doctor Ganapathy Arumugam, Managing Director & Group Science Director of EBTI said "our partnership with Clenergen allows for the commercialization of our plant science expertise in the field of genetic plant breeding, agronomy and microbiology. We can now provide a strong foundation for the production and supply of high yielding planting materials and crop based bioinputs. Together we aim to increase the productivity per unit area on a global scale for the cultivation of biomass as a non edible feedstock to be utilized as a source of renewable energy".

About Clenergen Corporation

Clenergen Corporation is a publicly listed company on the OTC stock market (symbol CRGE). Clenergen offers strategic Clean Energy Generation projects to address the requirement for renewable and sustainable supplies of electricity. Clenergen has developed a unique modular system of co-gasification and localized plantation management.

Using proprietary and mixed biomass feedstock to implement sustainable supplies of clean energy ([ www.clenergen.com/index.php?option=com_content&view=article&id=53&Itemid=37&lang=en ]) to regional, independent clients and national grids. The "Distributed Environmental Power System" marries significant proprietary advancements in plant science with proven long standing engineering technologies to achieve this goal. [ www.clenergen.com ].

Notice Regarding Forward-Looking Statements

This press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to our ability to establish our company as one of the leading biomass energy generating companies globally.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with clean technologies; changes in the operating costs and changes in economic conditions and conditions in clean technologies. These forward-looking statements are made as of the date of this press release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance those beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our current and periodic reports filed from time-to-time with the Securities and Exchange Commission.


Similar Business and Finance Articles